Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advancements and challenges in CAR T cell therapy in autoimmune diseases.
Schett G, Müller F, Taubmann J, Mackensen A, Wang W, Furie RA, Gold R, Haghikia A, Merkel PA, Caricchio R, D'Agostino MA, Locatelli F, June CH, Mougiakakos D. Schett G, et al. Among authors: caricchio r. Nat Rev Rheumatol. 2024 Sep;20(9):531-544. doi: 10.1038/s41584-024-01139-z. Epub 2024 Aug 6. Nat Rev Rheumatol. 2024. PMID: 39107407 Review.
Phenotype Systemic Lupus Erythematosus Patients from EPIC Cosmos.
Patel J, Yao L, Vina E, Fleece D, Arundathi J, Caricchio R, Wu H. Patel J, et al. Among authors: caricchio r. Stud Health Technol Inform. 2024 Jan 25;310:159-163. doi: 10.3233/SHTI230947. Stud Health Technol Inform. 2024. PMID: 38269785
Systemic Lupus Erythematosus and Cytokine Storm.
Caricchio R, Gallucci S. Caricchio R, et al. Adv Exp Med Biol. 2024;1448:355-364. doi: 10.1007/978-3-031-59815-9_24. Adv Exp Med Biol. 2024. PMID: 39117826 Review.
The intersection of COVID-19 and autoimmunity.
Knight JS, Caricchio R, Casanova JL, Combes AJ, Diamond B, Fox SE, Hanauer DA, James JA, Kanthi Y, Ladd V, Mehta P, Ring AM, Sanz I, Selmi C, Tracy RP, Utz PJ, Wagner CA, Wang JY, McCune WJ. Knight JS, et al. Among authors: caricchio r. J Clin Invest. 2021 Dec 15;131(24):e154886. doi: 10.1172/JCI154886. J Clin Invest. 2021. PMID: 34710063 Free PMC article. Review.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group. Marconi VC, et al. Lancet Respir Med. 2021 Dec;9(12):1407-1418. doi: 10.1016/S2213-2600(21)00331-3. Epub 2021 Sep 1. Lancet Respir Med. 2021. PMID: 34480861 Free PMC article. Clinical Trial.
Calming the cytokine storm in COVID-19.
Cron RQ, Caricchio R, Chatham WW. Cron RQ, et al. Among authors: caricchio r. Nat Med. 2021 Oct;27(10):1674-1675. doi: 10.1038/s41591-021-01500-9. Nat Med. 2021. PMID: 34480126 No abstract available.
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.
Caricchio R, Abbate A, Gordeev I, Meng J, Hsue PY, Neogi T, Arduino R, Fomina D, Bogdanov R, Stepanenko T, Ruiz-Seco P, Gónzalez-García A, Chen Y, Li Y, Whelan S, Noviello S; CAN-COVID Investigators. Caricchio R, et al. JAMA. 2021 Jul 20;326(3):230-239. doi: 10.1001/jama.2021.9508. JAMA. 2021. PMID: 34283183 Free PMC article. Clinical Trial.
70 results